Avextra Pharma

This sponsor has funded 3 studies across 1 countries.

PAS funded by this sponsor.
EU PAS ID Status Title Protocol uploaded Results uploaded
106292 Finalised Exploratory non-interventional, open-label, prospective, longitudinal 12-week parallel group study to assess the efficacy and safety of a balanced... No No
106298 Finalised Exploratory non-interventional, open-label, prospective, longitudinal 12-week parallel group study to assess the efficacy and safety of a balanced... No No
107696 Ongoing Eine nicht-interventionelle, offene, prospektive Studie zur Beurteilung des Einflusses und der Sicherheit eines ausgewogenen (10mg:10mg)... No No

PAS by Risk Management Plan (RMP) requirement

Avextra Pharma

The RMP for a medical product outlines strategies to identify, assess, and mitigate risks, including PAS for further evaluation.

Category 1 studies are imposed as condition of marketing authorisation.
Category 2 studies are imposed as specific obligation of marketing authorisation.
Category 3 studies are required under other circumstances.